Treace Medical Concepts, Inc. Stock

Equities

TMCI

US89455T1097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
4.94 USD -1.20% Intraday chart for Treace Medical Concepts, Inc. +9.05% -61.25%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 205M Sales 2025 * 230M Capitalization 306M
Net income 2024 * -55M Net income 2025 * -51M EV / Sales 2024 * 1.5 x
Net Debt 2024 * 2.1M Net Debt 2025 * 34.79M EV / Sales 2025 * 1.48 x
P/E ratio 2024 *
-5.46 x
P/E ratio 2025 *
-5.83 x
Employees 516
Yield 2024 *
-
Yield 2025 *
-
Free-Float 68.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.20%
1 week+9.05%
Current month-52.36%
1 month-54.97%
3 months-67.69%
6 months-42.49%
Current year-61.25%
More quotes
1 week
4.86
Extreme 4.8601
6.01
1 month
3.92
Extreme 3.92
11.39
Current year
3.92
Extreme 3.92
15.98
1 year
3.92
Extreme 3.92
27.70
3 years
3.92
Extreme 3.92
37.17
5 years
3.92
Extreme 3.92
37.17
10 years
3.92
Extreme 3.92
37.17
More quotes
Managers TitleAgeSince
Founder 52 13-12-31
Director of Finance/CFO 54 20-08-31
Compliance Officer 49 22-09-30
Members of the board TitleAgeSince
Director/Board Member 66 20-11-19
Director/Board Member 65 15-02-28
Chairman 77 14-06-30
More insiders
Date Price Change Volume
24-05-20 4.94 -1.20% 1,048,259
24-05-17 5 -11.19% 2,044,656
24-05-16 5.63 -5.38% 1,927,179
24-05-15 5.95 +19.00% 3,371,960
24-05-14 5 +10.38% 4,103,380

Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT

More quotes
Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
4.94 USD
Average target price
6.833 USD
Spread / Average Target
+38.33%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW